Artiva Biotherapeutics (ARTV) Institutional Ownership $2.24 -0.06 (-2.61%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.24 -0.01 (-0.22%) As of 04/17/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Artiva Biotherapeutics (NASDAQ:ARTV)Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$179.58MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$90.23K Get ARTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARTV Institutional Buying and Selling by Quarter Artiva Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Deutsche Bank AG21,423$216K0.0%N/A0.088% 2/17/2025Bank of America Corp DE10,817$109K0.0%-39.3%0.045% 2/17/2025BNP Paribas Financial Markets9,879$100K0.0%+262.1%0.041% 2/14/2025Northern Trust Corp117,112$1.18M0.0%+3.8%0.482% 2/13/2025Barclays PLC24,161$244K0.0%+23.2%0.099% 2/13/2025Wells Fargo & Company MN8,616$87K0.0%+64.0%0.035% 2/12/2025Geode Capital Management LLC315,758$3.18M0.0%+2.2%1.300% 2/12/2025Norges Bank30,000$302K0.0%N/A0.124% 2/12/2025JPMorgan Chase & Co.37,619$379K0.0%+250.7%0.155% 2/6/2025Charles Schwab Investment Management Inc.43,526$439K0.0%+8.0%0.179% Get the Latest News and Ratings for ARTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/30/2025 Rhumbline Advisers12,879$130K0.0%-13.1%0.053% 1/24/2025China Universal Asset Management Co. Ltd.5,150$52K0.0%N/A0.021% 12/26/2024JPMorgan Chase & Co.10,726$166K0.0%N/A0.044% 11/27/2024Franklin Resources Inc.520,301$7.44M0.0%N/A2.142% 11/19/2024Barclays PLC19,616$304K0.0%N/A0.081% 11/16/2024Geode Capital Management LLC308,930$4.77M0.0%N/A1.272% 11/15/2024Barclays PLC19,616$304K0.0%N/A0.081% 11/15/2024Wellington Management Group LLP194,108$2.91M0.0%N/A0.799% 11/15/2024State Street Corp86,559$1.34M0.0%N/A0.356% 11/15/2024Samsara BioCapital LLC291,666$4.51M0.9%N/A1.201% 11/15/2024RA Capital Management L.P.9,853,302$152.23M1.8%N/A40.565% 11/15/2024RTW Investments LP148,844$2.30M0.0%N/A0.613% 11/14/2024Acuta Capital Partners LLC44,000$680K0.6%N/A0.181% 11/14/2024MetLife Investment Management LLC8,733$135K0.0%N/A0.036% 11/13/2024BNP Paribas Financial Markets2,728$42K0.0%N/A0.011% 11/12/2024Charles Schwab Investment Management Inc.40,293$623K0.0%N/A0.166% (Data available from 1/1/2016 forward) ARTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARTV shares? During the previous two years, 20 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), Geode Capital Management LLC ($3.18M), Wellington Management Group LLP ($2.91M), RTW Investments LP ($2.30M), and State Street Corp ($1.34M).Learn more on ARTV's institutional investors. Which institutional investors have been buying Artiva Biotherapeutics stock? Of the 18 institutional investors that purchased Artiva Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), RTW Investments LP ($148.84K), and State Street Corp ($86.56K). How much institutional buying is happening at Artiva Biotherapeutics? Institutional investors have bought a total of 11,662,341 shares in the last 24 months. This purchase volume represents approximately $179.58M in transactions. Which Artiva Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: Bank of America Corp DE ($7.00K), and Rhumbline Advisers ($1.95K). How much institutional selling is happening at Artiva Biotherapeutics? Institutional investors have sold a total of 8,951 shares in the last 24 months. This volume of shares sold represents approximately $90.23K in transactions. Related Companies CRDF Major Shareholders GOSS Major Shareholders DSGN Major Shareholders TVGN Major Shareholders HURA Major Shareholders MDWD Major Shareholders LFVN Major Shareholders ELDN Major Shareholders VYGR Major Shareholders PRME Major Shareholders This page (NASDAQ:ARTV) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTV Stock Free ARTV Stock Alerts